Atomo的血检产品亮相2014 AACC并荣获头奖
|
By LabMedica International staff writers Posted on 11 Sep 2014 |
|
澳大利亚墨尔本的Atomo诊断公司继在墨尔本举行的第20届国际艾滋病大会上成功亮相后，又在2014 AACC年会暨临床化验博览会上展出了一款一体化快速验血设备，面向美国市场。AtomoRapid全合一血液检验兼容多种病症的检测试纸，包括乳糜泻、过敏以及疟疾和人类免疫缺陷病毒(HIV)等传染病。
用该设备能在现场或家里进行更简单、更安全和更准确的检验，从而产生更好的临床结果。
在2014艾滋病大会上，Atomo诊断公司参加了世界卫生组织(WHO; Basel, Switzerland)组织的专场会议。专场会议的焦点是自助化验面临的机会和挑战以及讨论现实世界的情况。AtomoRapid全合一血检产品只有半个iPhone那么大，已在南非用于检测HIV和疟疾检验，欧盟正在进行临床实验，亚洲和美国的临床实验正在筹备。
前ResMed首席执行官、Atomo诊断公司创始人暨CEO John Kelly评论说：“我们从HIV和疟疾做起，因为在现场使用其它现有产品假阴性和假阳性有时超过10%，这对个人的影响最严重。”
澳大利亚政府计划放松对家庭HIV检验的限制，AtomoRapid HIV对于支持这一计划可能发挥重要作用。新南威尔士大学科尔比研究所最新的年度HIV监测报告称， 澳大利亚约30%的HIV患者被诊断出来时已过了本应开始治疗以恢复受损免疫系统的最佳时机。
John Kelly补充说：“我们与南非戴斯蒙•图图HIV基金会的合作研究表明，家庭检验如果要被接受，需要有能减少检验差错的一体化的直观解决方案。”Kelly的女儿得了一种儿童病，需要接受常规抽血做诊断检验，Kelly受此启发，发现了一种更好的验血方法。
AtomoRapid简便易用，因而能够实质性提高社区和家庭检验的可接受度和可靠性。该公司目前正计划在澳大利亚、美国和欧洲发布该产品的专业版和家用版。
每年全球售出逾1亿快速HIV检验，Atomo诊断公司正凭借其AtomoRapid创新向更用户友好的全合一解决方案过渡。
AtomoRapid上个月在纽约举行的医学设计优胜奖(MDEA)颁奖大会上荣获头奖，还被授予诸多其它殊荣。
Related Links:
Atomo诊断公司
世界卫生组织
科尔比研究所
用该设备能在现场或家里进行更简单、更安全和更准确的检验，从而产生更好的临床结果。
在2014艾滋病大会上，Atomo诊断公司参加了世界卫生组织(WHO; Basel, Switzerland)组织的专场会议。专场会议的焦点是自助化验面临的机会和挑战以及讨论现实世界的情况。AtomoRapid全合一血检产品只有半个iPhone那么大，已在南非用于检测HIV和疟疾检验，欧盟正在进行临床实验，亚洲和美国的临床实验正在筹备。
前ResMed首席执行官、Atomo诊断公司创始人暨CEO John Kelly评论说：“我们从HIV和疟疾做起，因为在现场使用其它现有产品假阴性和假阳性有时超过10%，这对个人的影响最严重。”
澳大利亚政府计划放松对家庭HIV检验的限制，AtomoRapid HIV对于支持这一计划可能发挥重要作用。新南威尔士大学科尔比研究所最新的年度HIV监测报告称， 澳大利亚约30%的HIV患者被诊断出来时已过了本应开始治疗以恢复受损免疫系统的最佳时机。
John Kelly补充说：“我们与南非戴斯蒙•图图HIV基金会的合作研究表明，家庭检验如果要被接受，需要有能减少检验差错的一体化的直观解决方案。”Kelly的女儿得了一种儿童病，需要接受常规抽血做诊断检验，Kelly受此启发，发现了一种更好的验血方法。
AtomoRapid简便易用，因而能够实质性提高社区和家庭检验的可接受度和可靠性。该公司目前正计划在澳大利亚、美国和欧洲发布该产品的专业版和家用版。
每年全球售出逾1亿快速HIV检验，Atomo诊断公司正凭借其AtomoRapid创新向更用户友好的全合一解决方案过渡。
AtomoRapid上个月在纽约举行的医学设计优胜奖(MDEA)颁奖大会上荣获头奖，还被授予诸多其它殊荣。
Related Links:
Atomo诊断公司
世界卫生组织
科尔比研究所
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Gold Member
Collection and Transport System
PurSafe Plus®
Rapid Molecular Testing Device
FlashDetect Flash10
Latest 行业新闻 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more